12 Takeaways From Questcor's Chart

Schaeffer's Investment Research
  SEP 24, 2013 3:03 PM

The fundamentals of this biopharmaceutical company look solid.

 


Questcor Pharmaceuticals (NASDAQ:QCOR) is a biopharmaceutical company that provides drugs for the treatment of multiple sclerosis, nephrotic syndrome, and infantile spasms indications.



What I Am Looking At:
 
Conclusion:  Looking for shares to resume uptrend from 80-day moving average pullback

This article by Tony Venosa, CMT, was originally published on Schaeffer's Investment Research.

Below, find some more great content from Schaeffer's Investment Research:


Daily Game Plan – Small Cap Leadership

Why Bonds Could Have Just Made a Major Low

Trading 101: Looking at a Calendar Spread


Twitter: @schaeffers
No positions in stocks mentioned.